Literature DB >> 23649093

Bovine respiratory syncytial virus and Histophilus somni interaction at the alveolar barrier.

J T Agnes1, B Zekarias, M Shao, M L Anderson, L J Gershwin, L B Corbeil.   

Abstract

Our previous studies showed that Histophilus somni and bovine respiratory syncytial virus (BRSV) act synergistically in vivo to cause more severe bovine respiratory disease than either agent alone causes. Since H. somni surface and secreted immunoglobulin binding protein A (IbpA) causes retraction of bovine alveolar type 2 (BAT2) cells and invasion between BAT2 cells in vitro, we investigated mechanisms of BRSV-plus-H. somni infection at the alveolar barrier. BRSV treatment of BAT2 cells prior to treatment with IbpA-rich H. somni concentrated culture supernatant (CCS) resulted in increased BAT2 cell rounding and retraction compared to those with either treatment alone. This mimicked the increased alveolar cell thickening in calves experimentally infected with BRSV followed by H. somni compared to that in calves infected with BRSV or H. somni alone. BRSV-plus-H. somni CCS treatment of BAT2 cells also enhanced paracellular migration. The effect of matrix metalloproteinases (MMPs) was investigated as well because microarray analysis revealed that treatment with BRSV plus H. somni synergistically upregulated BAT2 cell expression of mmp1 and mmp3 compared to that in cells treated with either agent alone. Enzyme-linked immunosorbent assay (ELISA) confirmed that MMP1 and MMP3 protein levels were similarly upregulated. In collagen I and collagen IV (targets for MMP1 and MMP3, respectively) substrate zymography, digestion was increased with supernatants from dually treated BAT2 cells compared with those from singly treated cells. Enhanced breakdown of collagen IV in the basal lamina and of fibrillar collagen I in the adjacent interstitium in the dual infection may facilitate dissemination of H. somni infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649093      PMCID: PMC3697614          DOI: 10.1128/IAI.00108-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Histophilus somni IbpA DR2/Fic in virulence and immunoprotection at the natural host alveolar epithelial barrier.

Authors:  Bereket Zekarias; Seema Mattoo; Carolyn Worby; Jason Lehmann; Ricardo F Rosenbusch; Lynette B Corbeil
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

Review 2.  Metalloproteinases and human placental invasiveness.

Authors:  M Cohen; A Meisser; P Bischof
Journal:  Placenta       Date:  2005-10-24       Impact factor: 3.481

Review 3.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses.

Authors:  Londa J Berghaus; Lynette B Corbeil; Roy D Berghaus; Warren V Kalina; Richard A Kimball; Laurel J Gershwin
Journal:  Vaccine       Date:  2006-04-17       Impact factor: 3.641

5.  Processing of tumour necrosis factor-alpha precursor by metalloproteinases.

Authors:  A J Gearing; P Beckett; M Christodoulou; M Churchill; J Clements; A H Davidson; A H Drummond; W A Galloway; R Gilbert; J L Gordon
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

6.  Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.

Authors:  H Nagase; J J Enghild; K Suzuki; G Salvesen
Journal:  Biochemistry       Date:  1990-06-19       Impact factor: 3.162

7.  IbpA DR2 subunit immunization protects calves against Histophilus somni pneumonia.

Authors:  R S Geertsema; B Zekarias; L La Franco Scheuch; C Worby; R Russo; L J Gershwin; D S Herdman; K Lo; L B Corbeil
Journal:  Vaccine       Date:  2011-05-08       Impact factor: 3.641

8.  Immune mechanisms of pathogenetic synergy in concurrent bovine pulmonary infection with Haemophilus somnus and bovine respiratory syncytial virus.

Authors:  Laurel J Gershwin; Londa J Berghaus; Karen Arnold; Mark L Anderson; Lynette B Corbeil
Journal:  Vet Immunol Immunopathol       Date:  2005-08-15       Impact factor: 2.046

9.  Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers.

Authors:  R Grant Rowe; Daniel Keena; Farideh Sabeh; Amanda L Willis; Stephen J Weiss
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-12       Impact factor: 5.464

10.  Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.

Authors:  Ralf Lichtinghagen; Petra B Musholt; Michael Lein; Andreas Römer; Birgit Rudolph; Glen Kristiansen; Steffen Hauptmann; Dietmar Schnorr; Stefan A Loening; Klaus Jung
Journal:  Eur Urol       Date:  2002-10       Impact factor: 20.096

View more
  12 in total

1.  Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection.

Authors:  O Supasorn; N Sringkarin; P Srimanote; P Angkasekwinai
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

2.  Histophilus somni Stimulates Expression of Antiviral Proteins and Inhibits BRSV Replication in Bovine Respiratory Epithelial Cells.

Authors:  C Lin; J T Agnes; N Behrens; M Shao; Y Tagawa; L J Gershwin; L B Corbeil
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

3.  Mycoplasma bovis and viral agents associated with the development of bovine respiratory disease in adult dairy cows.

Authors:  Thalita Evani Silva Oliveira; Isadora Fernanda Pelaquim; Eduardo Furtado Flores; Rodrigo Pelisson Massi; Milton James Jiménez Valdiviezo; Lucienne Garcia Pretto-Giordano; Amauri Alcindo Alfieri; João Paulo Elsen Saut; Selwyn Arlington Headley
Journal:  Transbound Emerg Dis       Date:  2019-06-24       Impact factor: 4.521

Review 4.  Evolving views on bovine respiratory disease: An appraisal of selected key pathogens - Part 1.

Authors:  Gerard M Murray; Rónan G O'Neill; Simon J More; Máire C McElroy; Bernadette Earley; Joseph P Cassidy
Journal:  Vet J       Date:  2016-10-08       Impact factor: 2.688

5.  Bovine respiratory syncytial virus infection enhances Pasteurella multocida adherence on respiratory epithelial cells.

Authors:  Putu Eka Sudaryatma; Kimika Nakamura; Hirohisa Mekata; Satoshi Sekiguchi; Meiko Kubo; Ikuo Kobayashi; Mawar Subangkit; Yoshitaka Goto; Tamaki Okabayashi
Journal:  Vet Microbiol       Date:  2018-04-30       Impact factor: 3.293

6.  Bovine Respiratory Syncytial Virus Decreased Pasteurella multocida Adherence by Downregulating the Expression of Intercellular Adhesion Molecule-1 on the Surface of Upper Respiratory Epithelial Cells.

Authors:  Putu Eka Sudaryatma; Akatsuki Saito; Hirohisa Mekata; Meiko Kubo; Watcharapong Fahkrajang; Tamaki Okabayashi
Journal:  Vet Microbiol       Date:  2020-06-02       Impact factor: 3.293

7.  Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.

Authors:  R F Foronjy; C C Taggart; A J Dabo; S Weldon; N Cummins; P Geraghty
Journal:  Mucosal Immunol       Date:  2014-07-09       Impact factor: 7.313

8.  Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.

Authors:  Jodi L McGill; Rachel A Rusk; Mariana Guerra-Maupome; Robert E Briggs; Randy E Sacco
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

9.  Development and optimization of a differentiated airway epithelial cell model of the bovine respiratory tract.

Authors:  Daniel Cozens; Edward Grahame; Erin Sutherland; Geraldine Taylor; Catherine C Berry; Robert L Davies
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

Review 10.  Histophilosis as a Natural Disease.

Authors:  D O'Toole; K S Sondgeroth
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.